Leishmaniasis can be treated with Selective Ribosome-Targeting Drug with Low Ototoxicity
September 3, 2015
In the new study, a team of researchers, led by Timor Baasov, professor at the Technion – Israel Institute of Technology (Haifa, Israel), investigated the